Covered recipient · General Payments record
KATHERINE ROSE-BORCHERDING
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$834.13
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.07 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $85.03 | 4 |
| Astellas Pharma US Inc | $81.46 | 4 |
| ABBVIE INC. | $46.37 | 2 |
| Lilly USA, LLC | $45.70 | 3 |
| Mylan Specialty L.P. | $23.14 | 1 |
| Acerta Pharma LLC | $16.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.40 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105973274 | CMS |
| ABBVIE INC. | $23.97 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105973276 | CMS |
| Astellas Pharma US Inc | $24.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323912 | CMS |
| Astellas Pharma US Inc | $19.87 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358503 | CMS |
| Astellas Pharma US Inc | $19.92 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139395089 | CMS |
| Astellas Pharma US Inc | $17.58 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139405383 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.37 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105533238 | CMS |
| GlaxoSmithKline, LLC. | $20.14 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116064279 | CMS |
| GlaxoSmithKline, LLC. | $26.92 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116563042 | CMS |
| GlaxoSmithKline, LLC. | $15.98 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116021518 | CMS |
| GlaxoSmithKline, LLC. | $21.99 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116667622 | CMS |
| Lilly USA, LLC | $13.20 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097268 | CMS |
| Lilly USA, LLC | $15.85 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135109824 | CMS |
| Lilly USA, LLC | $16.65 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097270 | CMS |
| Mylan Specialty L.P. | $23.14 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147327931 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.